Ecuador vs Slovakia: HIV-positive TB patients on ART (antiretroviral therapy)
Ecuador
100.0%
in 2024
Slovakia
100.0%
in 2021
Ecuador rank
1st
Slovakia rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Ecuador
- Slovakia
How they compare
Ecuador currently reports 100.0% against 100.0% in Slovakia, a difference of 0.0%.
The two have swapped places 2 times across 6 shared years of data; in 2009 it was Slovakia ahead.
Ecuador ranks 1st and Slovakia ranks 1st of 144 countries.
Across the 3 decades both report, Ecuador averaged higher in 1 and Slovakia in 1.
Head to head by decade
| Decade | Ecuador | Slovakia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 100.0% | 0.0% | — |
| 2010s | 97.3% | 91.7% | 5.7% | Ecuador |
| 2020s | 93.5% | 100.0% | 6.5% | Slovakia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Ecuador or Slovakia?
- Ecuador, at 100.0% against 100.0% in Slovakia as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Ecuador and Slovakia?
- 0.0%, with Ecuador ahead.
- How many years of comparable data are there for Ecuador and Slovakia?
- 6 years are reported by both, from 2009 to 2021.
- How do Ecuador and Slovakia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Ecuador ranks 1st and Slovakia ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.